º£½ÇºÚÁÏ

Experts from the º£½ÇºÚÁÏ lead on the Government’s cancer plan to prioritise childhood cancer care and improve diagnosis times for childhood cancer.

A major new study has found that transcranial magnetic stimulation (TMS), which applies magnetic energy to the brain, can be a cost-effective treatment option for the NHS in treating moderate and severe forms of depression that have not responded to other treatments.

Brain tumour patients and their families from across the East Midlands are gathering today (Wednesday 28 January) to mark the launch of a new research centre focused on finding a cure for the devastating disease

The largest liver study in the history of the NHS is due for roll out next year, with the aim of preventing thousands of people at risk of liver disease from needing hospital care.

A groundbreaking new study, led by experts at the º£½ÇºÚÁÏ, has found that medicines used to treat gout can also reduce the risk of heart attack and stroke in people with gout.

A new research project will look at how natural therapies work within the human body.

Experts in respiratory medicine have received funding to better understand how mucus is controlled in the lungs and how it contributes to severe asthma.

A º£½ÇºÚÁÏ technical specialist has been recognised by one of the UK’s most prestigious photography awards, with his work selected for nationwide public display as part of Britain’s largest annual photography exhibition.

Scientists from the º£½ÇºÚÁÏ are part of an international group of experts who have used cutting edge genomic technology to predict which koalas are at high risk of getting cancer, based on which retroviruses they inherited in their genes.

Shard Diagnostic has become the latest company to join the º£½ÇºÚÁÏ’s investment portfolio, supported through Nottingham Technology Ventures – the university’s wholly owned subsidiary responsible for managing its spin-out portfolio and related inves